Application of Next-Generation Sequencing to Realize Principles of Precision Therapy in Management of Cancer Patients
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Next-generation sequencing (NGS) is revolutionizing cancer diagnostics by identifying actionable mutations. This advanced technology offers higher sensitivity and broader gene coverage than traditional methods, enabling precision oncology.
Area Of Science
- Genomic Medicine
- Oncology
- Molecular Diagnostics
Background
- Cancers are characterized by genomic alterations, with a few actionable mutations driving disease progression.
- Traditional mutation testing methods (e.g., Sanger sequencing) have limitations in throughput and scope.
- Precision oncology relies on accurate identification of somatic and inherited mutations for tailored patient care.
Purpose Of The Study
- To highlight the critical role of next-generation sequencing (NGS) in modern cancer diagnostics and precision oncology.
- To compare the capabilities of NGS with traditional methods for mutation detection.
- To discuss the evolution and optimal application of NGS-based panels in clinical oncology.
Main Methods
- Review of next-generation sequencing (NGS) technologies and their application in cancer mutation profiling.
- Comparison of NGS with conventional methods like immunohistochemistry, Sanger sequencing, and allele-specific PCR.
- Discussion of various NGS panel designs, from hotspot to comprehensive exome/genome sequencing approaches.
Main Results
- NGS enables high-throughput, sensitive detection of diagnostic, prognostic, and predictive cancer mutations.
- NGS facilitates the identification of mutations in circulating tumor DNA (ctDNA) from liquid biopsies.
- NGS platforms have evolved from targeted panels to more comprehensive approaches, with panel-based testing remaining optimal for oncology practice.
Conclusions
- Next-generation sequencing (NGS) is a cornerstone of precision oncology, enabling comprehensive genomic profiling.
- NGS offers superior sensitivity and breadth for detecting both acquired and inherited cancer mutations compared to traditional methods.
- The ongoing evolution of NGS technologies, including whole exome and genome sequencing, promises further advancements in cancer diagnosis and treatment.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....